Michael Barbella, Managing Editor04.03.24
Imperative Care's executive team is looking a bit different these days. The company recently appointed Chuck Alpuche as chief operating officer (COO), Peter Griffin as senior vice president of Operations, Scott Elliott as chief legal officer (CLO), and Daniel Davis as chief strategy officer (CSO).
“This is an inflection point of operational scale and excellence for Imperative Care, and we are thrilled to have Chuck lead this important mission,” Imperative Care Chairman/CEO Fred Khosravi said. “Chuck and Peter together have made an indelible impact in elevating the treatment of diabetes, and they will turn their attention to doing the same for stroke and thrombectomy care. Scott brings a wealth of legal and strategic expertise that he has amassed through his career advising hypergrowth innovative companies. Daniel will continue his contributions to the future of patient care with his dedication to meaningful innovation.”
Alpuche brings more than 40 years of senior operational expertise to his role at Imperative Care. Prior to joining the company, he was executive vice president and COO of Insulet Corporation. Previously, he spent 30 years at PepsiCo in leadership roles overseeing domestic and international plant operations. Most recently, he was PepsiCo’s senior vice president of North America Beverages, and also worked as vice president and general manager, Concentrate Operations, Asia and Americas. Alpuche earned a bachelor of science degree in business administration from Delaware Valley College and an executive master of science degree in organizational management from the University of Pennsylvania. He serves on the Board of Directors of the L.S. Starrett Company and the non-profit organization Exceptional Minds.
Griffin joins Imperative Care as a seasoned operations leader with more than 35 years of manufacturing, strategic supplier management, and product development experience. His expertise is in operations management, product development, and supplier management. He most recently worked as group vice president and chief procurement officer at Insulet Corporation, and was previously the global leader of contract manufacturing at Harman International, managing the company’s entire automotive contract manufacturing engagements. He earned a bachelor of science degree in management, industrial engineering, from Worcester Polytechnic Institute, and an MBA from the F.W. Olin School of Business at Babson College.
Elliott joins the company with more than 30 years of experience as a strategic and legal advisor to high-growth companies and investors in various industries, including medical device. Throughout his legal career, he has acted as outside general counsel for companies at various stages and has advised boards of directors on governance issues, public and private financings, mergers and acquisitions, and other strategic transactions. Most recently, Elliott was a corporate partner at O’Melveny and Myers, LLP in the mergers and acquisitions group, and was co-head of the firm’s Life Sciences Practice, where he helped clients structure and negotiate transactions. Elliott earned a Juris Doctor degree from the University of California College of the Law, San Francisco, and a bachelor of arts degree from the University of California, Berkeley.
Davis will now oversee Imperative Care's growth and strategic initiatives.
“We foresee that the knowledge and expertise of these leaders—both within and outside of the medical device industry—will allow Imperative Care to take the next step forward in our mission to innovate and improve the entire continuum of patient care,” Khosravi stated.
Imperative Care is a commercial-stage medical technology company researching and developing connected innovations to elevate care for vascular disease patients. The company has four businesses focused on addressing specific gaps in treatment and care. The company is based in Campbell, Calif.
“This is an inflection point of operational scale and excellence for Imperative Care, and we are thrilled to have Chuck lead this important mission,” Imperative Care Chairman/CEO Fred Khosravi said. “Chuck and Peter together have made an indelible impact in elevating the treatment of diabetes, and they will turn their attention to doing the same for stroke and thrombectomy care. Scott brings a wealth of legal and strategic expertise that he has amassed through his career advising hypergrowth innovative companies. Daniel will continue his contributions to the future of patient care with his dedication to meaningful innovation.”
Alpuche brings more than 40 years of senior operational expertise to his role at Imperative Care. Prior to joining the company, he was executive vice president and COO of Insulet Corporation. Previously, he spent 30 years at PepsiCo in leadership roles overseeing domestic and international plant operations. Most recently, he was PepsiCo’s senior vice president of North America Beverages, and also worked as vice president and general manager, Concentrate Operations, Asia and Americas. Alpuche earned a bachelor of science degree in business administration from Delaware Valley College and an executive master of science degree in organizational management from the University of Pennsylvania. He serves on the Board of Directors of the L.S. Starrett Company and the non-profit organization Exceptional Minds.
Griffin joins Imperative Care as a seasoned operations leader with more than 35 years of manufacturing, strategic supplier management, and product development experience. His expertise is in operations management, product development, and supplier management. He most recently worked as group vice president and chief procurement officer at Insulet Corporation, and was previously the global leader of contract manufacturing at Harman International, managing the company’s entire automotive contract manufacturing engagements. He earned a bachelor of science degree in management, industrial engineering, from Worcester Polytechnic Institute, and an MBA from the F.W. Olin School of Business at Babson College.
Elliott joins the company with more than 30 years of experience as a strategic and legal advisor to high-growth companies and investors in various industries, including medical device. Throughout his legal career, he has acted as outside general counsel for companies at various stages and has advised boards of directors on governance issues, public and private financings, mergers and acquisitions, and other strategic transactions. Most recently, Elliott was a corporate partner at O’Melveny and Myers, LLP in the mergers and acquisitions group, and was co-head of the firm’s Life Sciences Practice, where he helped clients structure and negotiate transactions. Elliott earned a Juris Doctor degree from the University of California College of the Law, San Francisco, and a bachelor of arts degree from the University of California, Berkeley.
Davis will now oversee Imperative Care's growth and strategic initiatives.
“We foresee that the knowledge and expertise of these leaders—both within and outside of the medical device industry—will allow Imperative Care to take the next step forward in our mission to innovate and improve the entire continuum of patient care,” Khosravi stated.
Imperative Care is a commercial-stage medical technology company researching and developing connected innovations to elevate care for vascular disease patients. The company has four businesses focused on addressing specific gaps in treatment and care. The company is based in Campbell, Calif.